Clinical trial No longer in our active list Observational Ages 18 and up Women only

Analyzing Myometrial Cell Spillage During Minimally Invasive Hysterectomy

Official title: Prospective Analysis to Detect Myometrial Cells in Peritoneal Washing in Patients Undergoing Minimally Invasive Hysterectomy Using Containment Bag at University of Texas Medical Branch

Run by The University of Texas Medical Branch, Galveston · NCT05955651 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is trying to see if there is any spillage of uterine cells during a minimally invasive surgery for women with large uteri.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment50 (estimated)
SponsorThe University of Texas Medical Branch, Galveston
Academic / other
Drugs / interventionsradiation
Locations1 site (Galveston, Texas)
Trial IDNCT05955651 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18 and older undergoing minimally invasive hysterectomy for benign conditions with a uterus larger than 10 cm.

Probably not a fit

Patients with known gynecological malignancies or those requiring emergency hysterectomy will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to assess the spillage of endometrial and myometrial cells during total laparoscopic hysterectomy with manual morcellation in women with large uteri. It will involve 50 participants undergoing minimally invasive hysterectomy for benign conditions, with surgeries conducted between August 2023 and August 2024. Three samples of peritoneal washings will be collected at different stages of the procedure to evaluate cell spillage and sent for pathological analysis. The study is being conducted at the University of Texas Medical Branch.

Why it matters

Potential benefit: If successful, this study could improve surgical techniques and reduce the risk of cell spillage during hysterectomy procedures.

How similar studies have gone: While similar studies have explored cell spillage during hysterectomy, this specific approach using containment bags is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Women undergoing minimally invasive Laparoscopic / Robotic hysterectomy for presumably benign conditions such as (fibroids, adenomyosis, endometriosis, pelvic organ prolapse, abnormal uterine bleeding)
2. Large size uterus measuring more than 10 cm on US requiring cold knife morcellation within the Alexis containment bag, surgery will be done by designated surgeon at UTMB from 08/01/2023 to 08/01/2024.
3. Women 18 years and older
4. Subjects must be able to provide consents.
5. Normal endometrial biopsy.
6. Normal cervical cancer screening

Exclusion Criteria:

1. Known Gynecological malignancy.
2. Endometrial biopsy with endometrial intraepithelial hyperplasia.
3. History of exposure to pelvic radiation
4. Post-menopausal patients
5. Emergency hysterectomy
6. TDC patients
7. Patient less than 18 years old

Where it's running

  • University of Texas Medical branch
    Galveston, Texas, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.